Unlocking Life Sciences
You need more
With innovation and breakthroughs constantly emerging on the market, the Life Sciences industry is making impressive strides toward better health and quality of life for the global community. But, for companies and entrepreneurs working towards future discovery and development, there are many challenges to be met including preclinical and clinical trial risks, regulatory complexities, cost of lengthy development, processes, and capital financing strategies.
We have built a leading life sciences investment banking practice to help companies excel in this complex maze of opportunity and risk. Our clients turn to us as a strong, guiding partner with deep industry experience and extensive global relationships with strategic players and capital providers. Together we unlock the full potential of their company.
Healthcare & Life Sciences Investment Bank of the Year by Global Health and Pharmay
Valuation Firm of the Year by M&A Advisor
Best Expansion Capital Advisory by BNY Mellon
Life Science Tools & Diagnostics
Medical Devices & Equipment
Strategic capital & corporate development.
Throughout our tenure in the Life Science industry, we have recognized that our clients need more than just the “traditional” investment banking services. The unique challenges and opportunities inherent in Life Sciences must be met with highly specialized advisory services led by industry experienced professionals. To accomplish this, we create unique partnerships with our clients, providing them with a tailored set of services to amplify success across their lifecycle, from capital raising and strategic partnership to licensing and M&A.
We offer the full range of corporate development advisory to pre-revenue, early stage and growth stage Life Science companies to provide critical, experienced strategic guidance throughout every stage of building their business. As you build and prepare for the future, whether it consists of raising capital, licensing or pursuing M&A exit opportunities, we are committed to your success.
Relentlessly working to…
- Conduct a detailed business valuation to guide strategic decision-making
- Map the Company’s full range of strategic options and create a tailored strategy
- Identify high-fit investors, strategic partners and/or acquirers from a global set of industry relationships
- Engage investors, partners, and/or acquirers in a tailored version of the Company’s unique story that positions for maximum transaction value
Leverage our expertise.
As a team of senior investment bankers, we leverage our extensive life sciences industry experience and relationships with active investors, partners, and acquirers to create superior outcomes for our clients. With specialized knowledge of the science, market trends, and emerging value drivers, we skillfully showcase each company’s unique story, to achieve maximum value.
*Denotes engagements completed by an Objective Principal prior to joining Objective.
What others say about us...
“The OCP team are truly seller-goal oriented. You want a partner who shares your thought process and values — someone you are completely comfortable with and trust. I achieved that quickly with the OCP team. And, money isn’t the only consideration, there has to be advance thought put into what happens during and AFTER the deal is over so all objectives are hit — OCP does this exceptionally well.”
“I felt like we were partners in the process. We both had responsibilities and the partnership came through to achieve success. You don’t find that trust often in this business.”
“These guys are very organized and proactive in setting expectations for each phase. I was very impressed at how quickly and thoroughly they understood my business so soon after engaging with them. It showed me they had the right perspective to get the best return for me.”
“When you’re talking to a potential purchaser or investor, you want forward looking financials to be well thought through and 100% accurate. The highly-detailed financial projections OCP helped us develop gave us confidence that all possible scenarios had been thoroughly vetted — allowing expectations to be correctly set.”